Expression of the Biologically Active Insulin Analog SCI-57 in Nicotiana Benthamiana
Diabetes mellitus is a growing problem worldwide; however, only 23% of low-income countries have access to insulin, and ironically it costs higher in such countries than high-income ones. Therefore, new strategies for insulin and insulin analogs production are urgently required to improve low-cost a...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01335/full |
id |
doaj-c99bb38c1892476faeead14e2a528f40 |
---|---|
record_format |
Article |
spelling |
doaj-c99bb38c1892476faeead14e2a528f402020-11-24T21:18:38ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-11-011010.3389/fphar.2019.01335450709Expression of the Biologically Active Insulin Analog SCI-57 in Nicotiana BenthamianaAdriana Muñoz-Talavera0Miguel Ángel Gómez-Lim1Luis A. Salazar-Olivo2Jörg Reinders3Katharina Lim4Abraham Escobedo-Moratilla5Alberto Cristian López-Calleja6María Cristina Islas-Carbajal7Ana Rosa Rincón-Sánchez8Department of Physiology, Institute of Experimental and Clinical Therapeutics, University Center for Health Sciences, University of Guadalajara, Guadalajara, MexicoDepartment of Genetic Engineering, Center for Research and Advanced Studies of the National Polytechnic Institute, Irapuato, MexicoDivision of Molecular Biology, Institute for Scientific and Technological Research of San Luis Potosí, San Luis Potosí, MexicoScientific Support Unit Analytical Chemistry, Leibniz Research Centre for Working Environment and Human Factors, Dortmund, GermanyInstitute of Functional Genomics, University of Regensburg, Regensburg, GermanyCONACYT-Consortium for Research, Innovation, and Development of the Drylands (CIIDZA), IPICYT, San Luis Potosí, MexicoDepartment of Genetic Engineering, Center for Research and Advanced Studies of the National Polytechnic Institute, Irapuato, MexicoDepartment of Physiology, Institute of Experimental and Clinical Therapeutics, University Center for Health Sciences, University of Guadalajara, Guadalajara, MexicoInstitute of Molecular Biology and Gene Therapy, Department of Molecular Biology and Genomic, University Center for Health Sciences, University of Guadalajara, Guadalajara, MexicoDiabetes mellitus is a growing problem worldwide; however, only 23% of low-income countries have access to insulin, and ironically it costs higher in such countries than high-income ones. Therefore, new strategies for insulin and insulin analogs production are urgently required to improve low-cost access to therapeutic products, so as to contain the diabetes epidemic. SCI-57 is an insulin analog with a greater affinity for the insulin receptor and lower thermal degradation than native insulin. It also shows native mitogenicity and insulin-like biological activity. In this work, SCI-57 was transiently expressed in the Nicotiana benthamiana (Nb) plant, and we also evaluated some of its relevant biological effects. An expression plasmid was engineered to translate an N-terminal ubiquitin and C-terminal endoplasmic reticulum-targeting signal KDEL, in order to increase protein expression and stability. Likewise, the effect of co-expression of influenza M2 ion channel (M2) on the expression of insulin analog SCI-57 (SCI-57/M2) was evaluated. Although using M2 increases yield, it tends to alter the SCI-57 amino acid sequence, possibly promoting the formation of oligomers. Purification of SCI-57 was achieved by FPLC cation exchange and ultrafiltration of N. benthamiana leaf extract (NLE). SCI-57 exerts its anti-diabetic properties by stimulating glucose uptake in adipocytes, without affecting the lipid accumulation process. Expression of the insulin analog in agroinfiltrated plants was confirmed by SDS-PAGE, RP-HPLC, and MS. Proteome changes related to the expression of heterologous proteins on N. benthamiana were not observed; up-regulated proteins were related to the agroinfiltration process. Our results demonstrate the potential for producing a biologically active insulin analog, SCI-57, by transient expression in Nb.https://www.frontiersin.org/article/10.3389/fphar.2019.01335/fulldiabetesinsulin analog SCI-57proteomic profileNicotiana benthamianatransient expression3T3-L1 adipocytes |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Adriana Muñoz-Talavera Miguel Ángel Gómez-Lim Luis A. Salazar-Olivo Jörg Reinders Katharina Lim Abraham Escobedo-Moratilla Alberto Cristian López-Calleja María Cristina Islas-Carbajal Ana Rosa Rincón-Sánchez |
spellingShingle |
Adriana Muñoz-Talavera Miguel Ángel Gómez-Lim Luis A. Salazar-Olivo Jörg Reinders Katharina Lim Abraham Escobedo-Moratilla Alberto Cristian López-Calleja María Cristina Islas-Carbajal Ana Rosa Rincón-Sánchez Expression of the Biologically Active Insulin Analog SCI-57 in Nicotiana Benthamiana Frontiers in Pharmacology diabetes insulin analog SCI-57 proteomic profile Nicotiana benthamiana transient expression 3T3-L1 adipocytes |
author_facet |
Adriana Muñoz-Talavera Miguel Ángel Gómez-Lim Luis A. Salazar-Olivo Jörg Reinders Katharina Lim Abraham Escobedo-Moratilla Alberto Cristian López-Calleja María Cristina Islas-Carbajal Ana Rosa Rincón-Sánchez |
author_sort |
Adriana Muñoz-Talavera |
title |
Expression of the Biologically Active Insulin Analog SCI-57 in Nicotiana Benthamiana |
title_short |
Expression of the Biologically Active Insulin Analog SCI-57 in Nicotiana Benthamiana |
title_full |
Expression of the Biologically Active Insulin Analog SCI-57 in Nicotiana Benthamiana |
title_fullStr |
Expression of the Biologically Active Insulin Analog SCI-57 in Nicotiana Benthamiana |
title_full_unstemmed |
Expression of the Biologically Active Insulin Analog SCI-57 in Nicotiana Benthamiana |
title_sort |
expression of the biologically active insulin analog sci-57 in nicotiana benthamiana |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2019-11-01 |
description |
Diabetes mellitus is a growing problem worldwide; however, only 23% of low-income countries have access to insulin, and ironically it costs higher in such countries than high-income ones. Therefore, new strategies for insulin and insulin analogs production are urgently required to improve low-cost access to therapeutic products, so as to contain the diabetes epidemic. SCI-57 is an insulin analog with a greater affinity for the insulin receptor and lower thermal degradation than native insulin. It also shows native mitogenicity and insulin-like biological activity. In this work, SCI-57 was transiently expressed in the Nicotiana benthamiana (Nb) plant, and we also evaluated some of its relevant biological effects. An expression plasmid was engineered to translate an N-terminal ubiquitin and C-terminal endoplasmic reticulum-targeting signal KDEL, in order to increase protein expression and stability. Likewise, the effect of co-expression of influenza M2 ion channel (M2) on the expression of insulin analog SCI-57 (SCI-57/M2) was evaluated. Although using M2 increases yield, it tends to alter the SCI-57 amino acid sequence, possibly promoting the formation of oligomers. Purification of SCI-57 was achieved by FPLC cation exchange and ultrafiltration of N. benthamiana leaf extract (NLE). SCI-57 exerts its anti-diabetic properties by stimulating glucose uptake in adipocytes, without affecting the lipid accumulation process. Expression of the insulin analog in agroinfiltrated plants was confirmed by SDS-PAGE, RP-HPLC, and MS. Proteome changes related to the expression of heterologous proteins on N. benthamiana were not observed; up-regulated proteins were related to the agroinfiltration process. Our results demonstrate the potential for producing a biologically active insulin analog, SCI-57, by transient expression in Nb. |
topic |
diabetes insulin analog SCI-57 proteomic profile Nicotiana benthamiana transient expression 3T3-L1 adipocytes |
url |
https://www.frontiersin.org/article/10.3389/fphar.2019.01335/full |
work_keys_str_mv |
AT adrianamunoztalavera expressionofthebiologicallyactiveinsulinanalogsci57innicotianabenthamiana AT miguelangelgomezlim expressionofthebiologicallyactiveinsulinanalogsci57innicotianabenthamiana AT luisasalazarolivo expressionofthebiologicallyactiveinsulinanalogsci57innicotianabenthamiana AT jorgreinders expressionofthebiologicallyactiveinsulinanalogsci57innicotianabenthamiana AT katharinalim expressionofthebiologicallyactiveinsulinanalogsci57innicotianabenthamiana AT abrahamescobedomoratilla expressionofthebiologicallyactiveinsulinanalogsci57innicotianabenthamiana AT albertocristianlopezcalleja expressionofthebiologicallyactiveinsulinanalogsci57innicotianabenthamiana AT mariacristinaislascarbajal expressionofthebiologicallyactiveinsulinanalogsci57innicotianabenthamiana AT anarosarinconsanchez expressionofthebiologicallyactiveinsulinanalogsci57innicotianabenthamiana |
_version_ |
1726008093523836928 |